73
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Long Noncoding RNA GAS5 Accelerates Cholangiocarcinoma Progression by Regulating hsa-miR-1297

, , , , &
Pages 2745-2753 | Published online: 23 Mar 2021

References

  • Sempoux C, Jibara G, Ward SC, et al. Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis. 2011;4(31):49–60. doi:10.1055/s-0031-1272839
  • Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(2):2168–2179. doi:10.1016/S0140-6736(13)61903-024581682
  • Bragazzi MC, Ridola L, Safarikia S, et al. New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin. Ann Gastroenterol. 2018;31(5):42–55. doi:10.20524/aog.2017.020929333066
  • Patel T. New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma. J Gastroenterol. 2014;49(2):165–172. doi:10.1007/s00535-013-0894-y24145988
  • Smith-Cohn MA, Gill D, Voorhies BN, et al. Case report: pembrolizumab-induced type 1 diabetes in a patient with metastatic cholangiocarcinoma. Immunotherapy. 2017;9(2):797–804. doi:10.2217/imt-2017-004228877632
  • Yang J, Liu Y, Wang B, et al. Sumoylation in p27kip1 via RanBP2 promotes cancer cell growth in cholangiocarcinoma cell line QBC939. BMC Mol Biol. 2017;18(7):23–33. doi:10.1186/s12867-017-0100-528882106
  • Labib PL, Goodchild G, Pereira SP. Molecular pathogenesis of cholangiocarcinoma. BMC Cancer. 2019;19(1):185. doi:10.1186/s12885-019-5391-030819129
  • Bagante F, Gamblin TC, Pawlik TM. Cholangiocarcinoma risk factors and the potential role of aspirin. Hepatology. 2016;6(3):708–710. doi:10.1002/hep.28613
  • Bertone P, Stolc V, Royce TE. Global identification of human transcribed sequences with genome tiling arrays. Science. 2004;306(11):2242–2246. doi:10.1126/science.110338815539566
  • Zhao W, Dong S, Duan B. HOTAIR is a predictive and prognostic biomarker for patients with advanced gastric adenocarcinoma receiving fluorouracil and platinum combination chemotherapy. Am J Transl Res. 2015;1295‐1302.
  • Wei Y, Sun Q, Zhao L, et al. LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0/G1 cell cycle arrest in melanoma. Med Oncol. 2016;33(8):88–97. doi:10.1007/s12032-016-0804-227389544
  • Sand M, Bechara FG, Sand D, et al. Expression profiles of long noncoding RNAs in cutaneous squamous cell carcinoma. Epigenomics. 2016;8(4):501–518. doi:10.2217/epi-2015-001227067026
  • Ma SL, Li AJ, Hu ZY, et al. Coexpression of the carbamoylphosphate synthase 1 gene and its long noncoding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma. Mol Med Rep. 2015;12(9):7915–7926. doi:10.3892/mmr.2015.443526499888
  • Li J, Huang H, Li Y, et al. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer. Oncol Rep. 2016;36(5):3241. doi:10.3892/or.2016.520027779700
  • Fleming JV, Fontanier N, Harries DN, et al. The growth arrest genes gas5, gas6, and CHOP-10 (gadd153) are expressed in the mouse preimplantation embryo. Mol Reprod Dev. 1997;48(3):310–316. doi:10.1002/(SICI)1098-2795(199711)48:3<310::AID-MRD2>3.0.CO;2-U9322241
  • Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 1988;54(6):787–793. doi:10.1016/S0092-8674(88)91065-33409319
  • Tao R, Hu S, Wang S, et al. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma. Carcinogenesis. 2015;36(10):1136–1143. doi:10.1093/carcin/bgv09926163879
  • Cao S, Liu W, Li F, et al. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer. Int J Clin Exp Pathol. 2014;7(10):6776–6783.25400758
  • Liu B, Wu S, Ma J, et al. lncRNA GAS5 reverses EMT and tumor stem cell-mediated gemcitabine resistance and metastasis by targeting miR-221/SOCS3 in pancreatic cancer. Mol Ther Nucleic Acids. 2018;13:472–482. doi:10.1016/j.omtn.2018.09.02630388621
  • Wang K, Li J, Xiong G, et al. Negative regulation of lncRNA GAS5 by miR-196a inhibits esophageal squamous cell carcinoma growth. Biochem Biophys Res Commun. 2018;495(1):1151–1157. doi:10.1016/j.bbrc.2017.11.11929170131
  • Yang X, Xie Z, Lei X, et al. Long non-coding RNA GAS5 in human cancer. Oncol Lett. 2020;20(3):2587–2594. doi:10.3892/ol.2020.1180932782576
  • Yin D, He X, Zhang E, et al. Long non-coding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol. 2014;31(11):253. doi:10.1007/s12032-014-0253-825326054
  • Liu Z, Wang W, Jiang J, et al. Downregulation of GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6. PLoS One. 2013;8(9):e73991. doi:10.1371/journal.pone.007399124069260
  • Gu J, Wang Y, Wang X, et al. Effect of the lncRNA GAS5-miR-23a-ATG3 axis in regulating autophagy in patients with breast cancer. Cell Physiol Biochem. 2018;48(1):194–207. doi:10.1159/00049171830007957
  • Dong X, Kong C, Liu X, et al. GAS5 functions as a ceRNA to regulate hZIP1 expression by sponging miR-223 in clear cell renal cell carcinoma. Am J Cancer Res. 2018;8(8):1414–1426.30210913
  • Guo LL, Wang SF. Downregulated long noncoding RNA GAS5 fails to function as decoy of CEBPB, resulting in increased GDF15 expression and rapid ovarian cancer cell proliferation. Cancer Biother Radiopharm. 2019;1(2):1–10.
  • Gao W, Cao Y, Guo P, et al. Downregulation of MiR-1297 predicts poor prognosis and enhances gastric cancer cell growth by targeting CREB1. Biomed Pharmacother. 2019;9:413–419.
  • Liang L, Feng L, Wei B. microRNA-1297 involves in the progression of oral squamous cell carcinoma through PTEN. Saudi J Biol Sci. 2018;5(5):923–927. doi:10.1016/j.sjbs.2018.01.013